PlainPharmaWatch

CMS Open Payments · Tool

Alcon Vision LLC vs BeiGene USA, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Alcon Vision LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 244, versus 127 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Alcon Vision LLC
HHI 244 · top recipient 0.1%
Ranked #1,516 of 1,838 companies by HHI
BeiGene USA, Inc.
HHI 127 · top recipient 0.1%
Ranked #1,647 of 1,838 companies by HHI

Payment Overview

Company A

Alcon Vision LLC

Total Payments
$13.4M
% of Industry
0.1%
Transactions
94,278
Avg per Transaction
$141.71
Recipients
94,278
Avg per Recipient
$141.71
Payment Types
10
Top Payment Type
Food and Beverage
Company B

BeiGene USA, Inc.

Total Payments
$13.4M
% of Industry
0.1%
Transactions
12,014
Avg per Transaction
$1.1K
Recipients
11,760
Avg per Recipient
$1.1K
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Alcon Vision LLC vs BeiGene USA, Inc. - total reported payments in CMS Open Payments PY2024

BeiGene USA, Inc.$13.4MAlcon Vision LLC$13.4M

Payment Types Breakdown

Alcon Vision LLC

Food and Beverage $3.7M

27.4%

Consulting Fee $3.4M

25.8%

Royalty or License $3.2M

24.0%

Compensation for Services Other Than Consulting $1.6M

11.9%

Travel and Lodging $1.2M

9.1%

Grant $130.1K

1.0%

BeiGene USA, Inc.

Compensation for Services Other Than Consulting $1.6M

11.7%

Consulting Fee $896.6K

6.7%

Food and Beverage $382.3K

2.8%

Grant $299.8K

2.2%

Travel and Lodging $219.4K

1.6%

Education $41.21

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Alcon Vision LLC

  1. 1

    EDWIN H RYAN

    $1,477,877.65 · 7 txns

  2. 2

    Guy Kezirian

    $1,319,729.50 · 4 txns

  3. 3

    MARK C LOBANOFF

    $407,869.01 · 31 txns

  4. 4

    PREEYA KSHETTRY GUPTA

    $156,483.06 · 120 txns

  5. 5

    SAJJAD AKHTAR

    $149,614.35 · 10 txns

BeiGene USA, Inc.

  1. 1

    Dana-Farber Cancer Institute

    $250,000.00 · 1 txns

  2. 2

    IMADEDDINE TABBARA

    $88,106.05 · 49 txns

  3. 3

    ANDREW WHITELEY

    $81,945.85 · 46 txns

  4. 4

    CATHERINE C COOMBS

    $76,490.97 · 59 txns

  5. 5

    HAKAN KAYA

    $74,366.85 · 55 txns

Summary Comparison

Metric Alcon Vision LLC BeiGene USA, Inc.
Total Payments $13.4M $13.4M
% of Industry Total 0.1% 0.1%
Transaction Count 94,278 12,014
Avg per Transaction $141.71 $1.1K
Recipient Count 94,278 11,760
Avg per Recipient $141.71 $1.1K
Payment Type Count 10 6
Top Payment Type Food and Beverage Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.